The MarketWatch News Department was not involved in the creation of this content. The MAC lung disease market is predicted to grow in the coming years. This growth is mainly driven by the launch of ...
Goal to Accelerate Unblinding Phase 3 Data in Q2 2025 Ahead of Potential FDA Meeting MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (ANTX), a biopharmaceutical company focused on ...
Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback